Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,349,609
+$3,142,926 QoQ
Shares Held
461,742
+207.7% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 263 holders
Holding Since
Jun 2022
4 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. NVAX ranks #46 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
505,160 | $35,376,354 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
41,839 | $26,088,290 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
120,122 | $22,496,448 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
83,679 | $20,482,108 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
556,385 | $18,577,695 | |
| 6 | INSM |
INSMED Inc
|
156,553 | $16,691,680 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
275,712 | $15,164,160 | |
| 8 | EXEL |
Exelixis, Inc.
|
275,209 | $14,974,121 |
All Filings in NVAX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,349,609 | 461,742 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $1,206,683 | 150,085 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,419,877 | 666,657 | Shares | Sole | 2024-11-12 | |
| 2022-06-30 | $967,141 | 18,805 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||